- Joined
- 1 February 2007
- Posts
- 1,068
- Reactions
- 0
CUV Clinuvel have disappeared off the ASX list> They were a valid company last week. Have they gone in to liquidation or been taken over?
Is it the same blockbuster as 8 years ago? if so, they are really slow.Hey guys,
So first post, bringing a near 7 year old dead thread back to life is a great start! But it's better than starting a useless new thread i hope.
I've been looking into CUV for about a week now and i'm surprised by the apparent lack of interest in this company and this thread demonstrates this yet again. I'm a complete novice investor but i think (as does everyone else) that i can spot the next blockbuster when i see one.
What i understand about Clinuvels position is, EMA approval, possibly FDA approval in the next year and a decent market potential with a condition called EPP (just for appetisers). My question is, what are your feelings about CUV being the next big bio blockbuster, or have i missed a big piece of the puzzle?
Cheers.
I'm not sure what was happening 8 years ago. I was ready to buy some shares but i'm concerned the lack of interest means others are seeing what im not. I know a bit about pharmaceuticals and it seems they've got an effective, patented, approved drug. And as others here have said over a decade ago (haha) there's a lot of potential for such a drug.Is it the same blockbuster as 8 years ago? if so, they are really slow.
I'm not sure what was happening 8 years ago. I was ready to buy some shares but i'm concerned the lack of interest means others are seeing what im not. I know a bit about pharmaceuticals and it seems they've got an effective, patented, approved drug. And as others here have said over a decade ago (haha) there's a lot of potential for such a drug.
Had a look and it's interesting. The drug is expensive and I think there are less costly standard drugs based on cortesoids which do have side effects. I read the news letter and the CEO needs an editor. The drug works yet they are burning cash, why?
I think the next annual report will be interesting. If you are in now you may see a good rise when it's released. I will wait to get a comprehensive understanding. they are also on the Nasdaq so when that report will happen I am unsure.
"I read the news letter and the CEO needs an editor." I find this an extremely interesting comment, what did you see that makes you say that?!
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?